Studying non-invasive tests and factors in esophageal cancer patients
Studies patients with esophageal cancer using scans, questionnaires and nutrition assessments over time.
Plain-language title generated from the registry record
Registry title: Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
Key facts
- Where
- Budapest, HungarySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Have you had medicine for the cancer (such as chemotherapy) since it was found that it cannot be removed by surgery or has spread?
- Has your doctor told you that the cancer cannot be removed by surgery, or that it has spread to other parts of the body?
Source: NCT06713993, who can take part
Where in Hungary
- Semmelweis UniversityBudapest, HungaryTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Semmelweis University
- Trial code
- NCT06713993
- Record updated
- 24 April 2026
- Original description
The objective of this observational study was to gain a deeper understanding of the epidemiology of the disease in Hungary through a broad analysis of patients with new-onset esophageal-oesophageal-stomach junction tumors, and to identify key parameters that could potentially influence the outcome of the disease and are closely correlated with morbidity and mortality. The investigators' primary objective is to identify potential factors and conditions that could be influenced and modified to enhance the disease outcome.Read full original descriptionShow less
Noninvasive Testing Procedures, Role of Biomarkers and Anticancer Treatments in Esophageal and Esophagogastric Cancer Survival and Quality of Life of Patients With Cancer of the Esophageopharyngeal and Oesophageophageophageal Junction
The objective of this observational study was to gain a deeper understanding of the epidemiology of the disease in Hungary through a broad analysis of patients with new-onset esophageal-oesophageal-stomach junction tumors, and to identify key parameters that could potentially influence the outcome of the disease and are closely correlated with morbidity and mortality. The investigators' primary objective is to identify potential factors and conditions that could be influenced and modified to enhance the disease outcome.
Main questions:
1. What are the measurable changes in performance, workload, nutritional status, cardiac function, mental status in the patients studied? 2. What is the time course of the changes during and after treatment? 3. Which pathological parameters are associated with disease outcome and which are potential points of intervention to improve the course of the disease?
Patients will undergo a detailed physical and nutritional assessment, non-invasive imaging tests and several questionnaires in addition to the usual pre- and post-operative examinations.
Inclusion: Age over 18 years; Diagnosis of new-onset esophageal, esophagogastric junction tumor; Elective curative surgery (open/laparoscopic regardless of surgical technique); Patients who have not yet received oncological treatment for their present disease.
Exclusion: Contraindications for some studies: If MR scan is contraindicated, cardiac MR scan is not performed; Lack of consent; Lack of cooperation.